JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares (ZJYL) - Total Liabilities
Based on the latest financial reports, JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares (ZJYL) has total liabilities worth $23.80 Million USD as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares - Total Liabilities Trend (2018–2025)
This chart illustrates how JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares's total liabilities have evolved over time, based on quarterly financial data. See working capital to net assets of JIN MEDICAL INTERNATIONAL LTD. Ordinary to evaluate short-term liquidity relative to the company's equity base.
JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares Competitors by Total Liabilities
The table below lists competitors of JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Master Pack Group Bhd
KLSE:7029
|
Malaysia | RM22.17 Million |
|
Plastofil -L
TA:PPIL
|
Israel | ILA295.38 Million |
|
Matching Maximize Solution Public Company Limited
BK:MATCH
|
Thailand | ฿175.06 Million |
|
Alpha Group International plc
LSE:ALPH
|
UK | GBX294.65 Million |
|
CJ Century Logistics Holdings Bhd
KLSE:7117
|
Malaysia | RM287.14 Million |
|
ClearSign Combustion Corporation
NASDAQ:CLIR
|
USA | $2.65 Million |
|
INTERSHOP Communications Aktiengesellschaft
XETRA:ISHA
|
Germany | €22.65 Million |
|
Crypto Blockchain Industries SA
PA:ALCBI
|
France | €14.13 Million |
Liability Composition Analysis (2018–2025)
This chart breaks down JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see JIN MEDICAL INTERNATIONAL LTD. Ordinary market cap and net worth.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.86 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.80 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.45 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares (2018–2025)
The table below shows the annual total liabilities of JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares from 2018 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-09-30 | $23.80 Million | +37.96% |
| 2024-09-30 | $17.25 Million | +93.27% |
| 2023-09-30 | $8.92 Million | +56.46% |
| 2022-09-30 | $5.70 Million | -27.54% |
| 2021-09-30 | $7.87 Million | -21.38% |
| 2020-09-30 | $10.01 Million | +3.69% |
| 2019-09-30 | $9.66 Million | -0.22% |
| 2018-09-30 | $9.68 Million | -- |
About JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares
Jin Medical International Ltd. engages in the design, development, manufacture, and sale of wheelchair and other living aids for people with disabilities, the elderly, and people recovering from injury. The company offers wheelchairs and wheelchair components, such as wheels and brakes; oxygen concentrators, bath aids, and rehabilitative devices, as well as infrastructures for shared wheelchairs … Read more